(¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z Part 2. Ç×ü ¹× Ä¡·á¿ë ¾Ï¹é½Å °³¹ß : 2021-12-03±³À°ÀÏÀÚ : 2021-12-03
±³À°Àå¼Ò : ±¹¸³¾Ï¼¾ÅÍ °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z Part 2. Ç×ü ¹× Ä¡·á¿ë ¾Ï¹é½Å °³¹ßÁÖÃÖ±â°ü : ±¹¸³¾Ï¼¾ÅÍ
´ã´çÀÚ : ¹Ú¼ö¿¬
¿¬¶ôó : 031-920-0037
À̸ÞÀÏ :
chungga96@ncc.re.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú¿¹¹æÀÇÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:30~13:35 °³È¸»ç ±è¿µ¿ì(±¹¸³¾Ï¼¾ÅÍ ¿¬±¸¼ÒÀå)
±âŸ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:35~13:40 Ãà»ç ¼È«°ü(±¹¸³¾Ï¼¾ÅÍ ¿øÀå)
±³À°½Ã°£ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:40~14:15 4-1BB immunobiology and current clinical trials ±Çº´¼¼(¢ßÀ¯Æ¿·º½º(Eutilex) ´ëÇ¥ÀÌ»ç(CEO Chief Executive Officer))
±³À°½Ã°£ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 14:15~14:50 GX-188E: Therapeutic DNA vaccine against HPV-16 or –18 caused recurrent/advanced cervical cancer ¹ÚÁ¾¼·(¢ßÁ¦³Ø½Å(Genexine) »óÀÓ°í¹® (CMO Chief Medical Officer))
ÈÞ½Ä 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 14:50~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 15:00~15:35 Emerging concepts and technologies on personalized therapeutic cancer vaccines Á¤ÁØÈ£(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç ±³¼ö)
±³À°½Ã°£ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 15:35~16:10 Peptide drug development ¹Ú¿ø¿µ(¢ß¾Ö´ÏÁ¨ ¿µ¾÷°æ¿µ»ç¾÷º»ºÎÀå)
±³À°½Ã°£ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 16:10~16:45 Neoantigen ion for cancer immunotherapy ÀÌÁ¦¿í(¿À¼Û÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü½Å¾à°³¹ßÁö¿ø¼¾ÅÍÀå)
ÈÞ½Ä 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 16:45~16:55 ÈÞ½Ä ()
Åä·Ð 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 16:55~17:00 ÆгÎÅä·Ð Á¤ÁØÈ£(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç ±³¼ö)
Åä·Ð 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:00~17:05 ÆгÎÅä·Ð ±èÇбÕ(±¹¸³¾Ï¼¾ÅÍ Ç׾Ͻžà½ÅÄ¡·á°³¹ß»ç¾÷´Ü ºÎ´ÜÀå/ ±¹¸³¾Ï¼¾ÅÍ Ç÷¾×Á¾¾ç³»°úºÐ°ú Àü¹®ÀÇ)
Åä·Ð 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:05~17:10 ÆгÎÅä·Ð ¹é¼ø¸í(¢ßÅ׶óÁ¨¹ÙÀÌ¿À(Theragen Bio) ¿¬±¸¼ÒÀå)
Åä·Ð 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:10~17:20 ÆгÎÅä·Ð °Ã¢À²(¢ß¼¿¸®µå(Cellid) ´ëÇ¥ÀÌ»ç/ ¼¿ï´ëÇб³ ¾àÇдëÇÐ ¸í¿¹±³¼ö)
Åä·Ð 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:20~17:30 ÆгÎÅä·Ð ¿ÀÀÏ¿õ(½ÄÇ°ÀǾàÇ°¾ÈÀüÆò°¡¿ø ¹ÙÀÌ¿À»ý¾à½É»çºÎ ¼¼Æ÷À¯ÀüÀÚÄ¡·áÁ¦°úÀå)
±âŸ 12-03 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:30~17:35 Æóȸ»ç ¹ÚÁß¿ø(±¹¸³¾Ï¼¾ÅÍ Ç׾Ͻžà½ÅÄ¡·á°³¹ß»ç¾÷´ÜÀå)